Drugs News and Research

RSS

Using common pain relievers during acute respiratory infection linked to increased heart attack risk

Widely used pain relievers may increase the risk of a heart attack when used during a cold or flu-like illness, according to a new study published in the Journal of Infectious Diseases.

2 Feb 2017

SLU scientists receive $416,000 NIH grant to advance research on hepatitis B cure

With a $416,000 grant from the National Institutes of Health (NIH), SLU scientists will continue work to cure hepatitis B, building on significant findings published in two recent papers.

1 Feb 2017

Taking multiple medications linked to frailty in older adults

As we age, we tend to develop a number of chronic health conditions and concerns. Often, managing health problems can mean that older adults may take many different medications. When older adults take five or more medicines (a scenario called "polypharmacy" by health experts), it can increase the risk for harmful side effects.

1 Feb 2017

Habitual e-cigarette use may be linked to long-term cardiac risks, study finds

A study published in JAMA Cardiology has added to growing evidence that electronic cigarettes (e-cigarettes) are not harmless.

1 Feb 2017

Scientists discover way of improving immune system’s memory to recognise and fight cancers

Scientists from the University of Southampton have discovered an important way that the immune system can learn to recognise and fight cancers.

1 Feb 2017

Non-severe infections can increase risk of developing serious mental disorders

A new study shows that non-severe infections that do not require hospitalisation can also increase the risk of subsequently developing schizophrenia or depression.

1 Feb 2017

Researchers reveal how soy consumption impacts common breast cancer treatment

Georgetown Lombardi Comprehensive Cancer Center researchers have used animal models to reveal new information about the impact - positive and negative - that soy consumption could have on a common breast cancer treatment.

1 Feb 2017

Canada has second-highest prevalence of skipped prescriptions due to cost, UBC research finds

One in 12 Canadians aged 55 and older skipped prescriptions due to cost in 2014, the second-highest rate among comparable countries, new UBC research has found.

1 Feb 2017

EU experts discuss how to reverse HIV epidemic in Europe

In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.

1 Feb 2017

New research finds increase in mortality rates caused by drugs, alcohol and suicide

Nationwide, the mortality rate from deaths caused by drugs, alcohol and suicide rose 52 percent from 2000 to 2014, according to new research from the Carsey School of Public Policy at the University of New Hampshire.

1 Feb 2017

Research sheds new light on how dengue virus inflicts more damage during subsequent infections

For most people who contract it, dengue fever is a relatively mild-mannered disease--at least the first time around. For some, however, a subsequent infection by the virus unleashes a vicious and potentially deadly illness.

31 Jan 2017

Scientists shed new light on how common painkiller causes liver damage

Scientists have shed new light on how the common painkiller paracetamol causes liver damage.

31 Jan 2017

Microsystems engineer wins award for dissertation on optimization of biosensors for diagnosing diseases

The microsystems engineer Dr. Can Dincer from University of Freiburg has been awarded by the second place in Gips-Schüle Young Scientist Award for his dissertation on the optimization of biosensor systems for diagnosing diseases.

31 Jan 2017

Johns Hopkins researchers uncover mechanism in chikungunya virus that controls disease severity

Researchers led by the Johns Hopkins Bloomberg School of Public Health have identified a mechanism by which the chikungunya virus infects healthy cells and controls how severe the disease it causes will be, a mechanism they believe can be found in a number of other related viruses for which there are no treatments or licensed vaccines.

31 Jan 2017

NIH awards grant to UND study that focuses on early formation of cancer-causing viruses

The list is long. From the common cold and influenza to HIV and measles, and from Zika to some cancers, all are caused by viruses — tiny packages of either DNA or RNA that wear a protein coat.

31 Jan 2017

Researchers develop online resource to gather, organize research information on cancer mutations

The body of knowledge on cancer genomics is massive and ever-expanding. But this wealth of potentially critical information is far less likely to be of help to patients if it is inaccessible to the doctors who treat them.

31 Jan 2017

Novel potassium channel genes could be promising therapeutic targets for alcohol use disorder

A handful of FDA-approved drugs exist for treating individuals with alcohol use disorder but they have been largely ineffective at reducing the high rates of relapse. As such, there remains a critical need to identify and develop alternative pharmacological treatment options.

31 Jan 2017

Research consortium awarded $21 million NIH grant to find ways to prevent epilepsy in patients with TBI

An international consortium of academic research institutions have been awarded a $21 million grant from the National Institutes of Health to develop better ways to prevent epilepsy in patients who have suffered traumatic brain injuries.

30 Jan 2017

Researchers discover that existing anti-gout drug can reduce severity of opioid withdrawal symptoms

Opioid use and abuse is a significant social, health and economic issue in Canada. Researchers at the University of Calgary's Faculty of Veterinary Medicine and Hotchkiss Brain Institute have discovered that an existing anti-gout medication is effective in reducing the severity of withdrawal symptoms in opioid-dependent rodents.

30 Jan 2017

First-time drug trials launched on basis of flimsy, under-scrutinized evidence, say McGill researchers

Standards for authorizing first-time trials of drugs in humans are lax, and should be strengthened in several ways, McGill University researchers argue in a paper published today in Nature.

30 Jan 2017

Drugs News and Research

Using common pain relievers during acute respiratory infection linked to increased heart attack risk

SLU scientists receive $416,000 NIH grant to advance research on hepatitis B cure

Taking multiple medications linked to frailty in older adults

Habitual e-cigarette use may be linked to long-term cardiac risks, study finds

Scientists discover way of improving immune system’s memory to recognise and fight cancers

Non-severe infections can increase risk of developing serious mental disorders

Researchers reveal how soy consumption impacts common breast cancer treatment

Canada has second-highest prevalence of skipped prescriptions due to cost, UBC research finds

EU experts discuss how to reverse HIV epidemic in Europe

New research finds increase in mortality rates caused by drugs, alcohol and suicide

Research sheds new light on how dengue virus inflicts more damage during subsequent infections

Scientists shed new light on how common painkiller causes liver damage

Microsystems engineer wins award for dissertation on optimization of biosensors for diagnosing diseases

Johns Hopkins researchers uncover mechanism in chikungunya virus that controls disease severity

NIH awards grant to UND study that focuses on early formation of cancer-causing viruses

Researchers develop online resource to gather, organize research information on cancer mutations

Novel potassium channel genes could be promising therapeutic targets for alcohol use disorder

Research consortium awarded $21 million NIH grant to find ways to prevent epilepsy in patients with TBI

Researchers discover that existing anti-gout drug can reduce severity of opioid withdrawal symptoms

First-time drug trials launched on basis of flimsy, under-scrutinized evidence, say McGill researchers

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News